{"cik":1322505,"taxonomy":"us-gaap","tag":"OtherAssetsCurrent","label":"Other Assets, Current","description":"Amount of current assets classified as other.","entityName":"ALBIREO PHARMA, INC.","units":{"USD":[{"end":"2020-12-31","val":3029000,"accn":"0001558370-22-002501","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-01","frame":"CY2020Q4I"},{"end":"2021-12-31","val":12096000,"accn":"0001558370-22-002501","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-01"},{"end":"2021-12-31","val":12096000,"accn":"0001558370-22-008984","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-16"},{"end":"2021-12-31","val":12096000,"accn":"0001558370-22-013652","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15"},{"end":"2021-12-31","val":12096000,"accn":"0001558370-22-016893","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-08","frame":"CY2021Q4I"},{"end":"2022-03-31","val":2490000,"accn":"0001558370-22-008984","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-16","frame":"CY2022Q1I"},{"end":"2022-06-30","val":2666000,"accn":"0001558370-22-013652","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15","frame":"CY2022Q2I"},{"end":"2022-09-30","val":2666000,"accn":"0001558370-22-016893","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-08","frame":"CY2022Q3I"}]}}